Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older

Authors :: Falsey, Ann R.
Treanor, John J.
Tornieporth, Nadia
Capellan, Jose
Gorse, Geoffrey J.
Source :: Journal of Infectious Diseases. July 15, 2009, Vol. 200 Issue 2, p172, 9 p.
Publication Year :: 2009

Subjects :: Immunogenetics -- Comparative analysis
Influenza vaccines -- Dosage and administration
Drug therapy -- Usage
Drug therapy -- Patient outcomes
Influenza -- Drug therapy
Influenza -- Patient outcomes
Health

Tools